Stuttering Priapism in a Teenage Boy: Lesson to be Learnt.
Journal
Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928
Informations de publication
Date de publication:
01 11 2021
01 11 2021
Historique:
received:
26
08
2020
accepted:
08
10
2020
pubmed:
26
11
2020
medline:
6
1
2022
entrez:
25
11
2020
Statut:
ppublish
Résumé
Untreated priapism can lead to ischemic damage of the penis and impotence. This case report describes a 14-year-old boy who presented with a history of priapism for 2 months, which was undiagnosed, ridiculed, and ignored even by medical practitioners. The underlying etiology was later identified to be chronic myeloid leukemia. Despite the usage of multimodal treatment, it took 7 days for control of priapism. The young boy is now left with an erectile dysfunction. The case highlights that priapism in children is a medical emergency needing aggressive evaluation and treatment.
Identifiants
pubmed: 33235144
pii: 00043426-202111000-00021
doi: 10.1097/MPH.0000000000001998
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1118-e1119Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Minckler MR, Conser E, Figueroa JJ, et al. The semantics of priapism and the first sign of chronic myeloid leukemia. Case Rep Emerg Med. 2017;2017:2656203.
Salonia A, Eardley I, Giuliano F, et al. European Association of Urology guidelines on priapism. Eur Urol. 2014;65:480–489.
Donaldson JF, Rees RW, Steinbrecher HA. Priapism in children: a comprehensive review and clinical guideline. J Pediatr Urol. 2014;10:11–24.
Liguori G, Bucci S, Benvenuto S, et al. Priapism: pathophysiology and management. J Androl Sci. 2009;16:13–20.
Rodgers R, Latif Z, Copland M. How I manage priapism in chronic myeloid leukaemia patients. Br J Haematol. 2012;158:155–164.
Kurosawa H, Tanizawa A, Tono C, et al. Leukostasis in children and adolescents with chronic myeloid leukemia: Japanese pediatric leukemia/lymphoma study group. Pediatr Blood Cancer. 2016;63:406–411.
Ponniah A, Brown CT, Taylor P. Priapism secondary to leukemia: effective management with prompt leukapheresis. Int J Urol. 2004;11:809–810.
Montague DK, Jarow J, Broderick GA, et al. Erectile Dysfunction Guideline Update Panel. American Urological Association guideline on the management of priapism. J Urol. 2003;170(pt 1):1318–1324.
Levey HR, Segal RL, Bivalacqua TJ. Management of priapism: an update for clinicians. Ther Adv Urol. 2014;6:230–244.
Shiraishi K, Matsuyama H. Salvage management of prolonged ischemic priapism: Al-Ghorab shunt plus cavernous tunneling with blunt cavernosotomy. J Sex Med. 2013;10:599–602.
Veljković D, Kuzmanović M, Mićić D, et al. Leukapheresis in management hyperleucocytosis induced complications in two pediatric patients with chronic myelogenous leukemia. Transfus Apher Sci. 2012;46:263–267.
Ralph DJ, Garaffa G, Muneer A, et al. The immediate insertion of a penile prosthesis for acute ischaemic priapism. Eur Urol. 2009;56:1033–1038.
Herschorn S, Ordorica RC. Penile prosthesis insertion with corporeal reconstruction with synthetic vascular graft material. J Urol. 1995;154:80–84.
Becerra-Pedraza LC, Jiménez-Martínez LE, Peña-Morfin I, et al. Priapism as the initial sign in hematologic disease: case report and literature review. Int J Surg Case Rep. 2018;43:13–17.
Musa AU, Ndakotsu MA, Abubakar SB, et al. Chronic myeloid leukemia with an initial presentation as ischemic priapism: a case report and review of literature. Arch Int Surg. 2017;7:68–72.